Ansell cuts dividend after profit drops by 48pct

Sales were down 2.2 per cent to $US1.62 billion ($A2.4 billion), which Ansell attributed in part to healthcare customers continuing to draw down on inventory built up during the COVID-19 pandemic.

Ansell CEO Neil Salmon said the company achieved its key performance objectives, with sales and earnings improving as healthcare end market conditions normalised.

"We exit FY24 with good momentum and with post-pandemic market disruptions largely behind us we look forward to returning the business to organic growth in FY25," Mr Salmon said.

Ansell will pay a final dividend of US21.90¢ per share, taking total dividend for the full year to US38.40¢, down 16.3 per cent from 2022/23.